Synthomer (LON:SYNT - Get Free Report) had its price objective cut by stock analysts at Berenberg Bank from GBX 265 ($3.31) to GBX 230 ($2.87) in a report released on Monday, MarketBeat reports. The firm presently has a "buy" rating on the stock. Berenberg Bank's price target points to a potential upside of 64.29% from the company's previous close.
Separately, Canaccord Genuity Group lowered their target price on Synthomer from GBX 300 ($3.74) to GBX 275 ($3.43) and set a "buy" rating for the company in a research note on Friday, October 4th.
Get Our Latest Stock Analysis on Synthomer
Synthomer Price Performance
Synthomer stock traded down GBX 11.40 ($0.14) during mid-day trading on Monday, hitting GBX 140 ($1.75). 975,343 shares of the company were exchanged, compared to its average volume of 428,460. Synthomer has a 1-year low of GBX 118 ($1.47) and a 1-year high of GBX 338 ($4.22). The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 77.42. The business has a fifty day moving average of GBX 168.03 and a 200 day moving average of GBX 210.77. The company has a market capitalization of £229.00 million, a PE ratio of -229.51, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Featured Articles
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.